Monday 26 October 2026
The deal, announced October 20, places Orchestra’s clinical-trial agents inside OpenAI’s Rosalind unit after a year of large AI health investments and mixed clinical evidence.
In a 455-patient Phase III trial, median progression-free survival was 15.0 months versus 5.7 months with chemotherapy plus pembrolizumab.
Authorities are tracking 53 people who had contact with the patient. The outbreak has reached 9,735 confirmed cases and is the second-largest recorded.
Interim Phase 3 DeLLphi-305 data showed median overall survival of 21.1 months with tarlatamab plus durvalumab versus 12.7 months with durvalumab alone in extensive-stage small cell lung cancer.
In a randomized trial of more than 1,100 people after high-risk melanoma surgery, 82% receiving the vaccine combination were recurrence-free at two years, versus 70% on Keytruda alone.
In 1,174 participants, neoadjuvant pembrolizumab plus chemotherapy led to a pathologic complete response rate of 64.0 percent compared with 54.7 percent with placebo plus chemotherapy, p=0.00221.
At week 48, 0.8% of participants on the fixed-dose combination and 1.1% on a stable baseline regimen had HIV-1 RNA of at least 50 copies/mL, according to the registry posting.
In phase 3 trials, about one in five adults reached a functional cure after a six-month course, but a boxed warning requires close monitoring.
The notice explains which software outputs distributed by sponsors of prescription drugs and drug-led combination products fall under FDA labeling rules.
A 10-member FDA advisory committee voted 10-0 on safety, 6-4 on effectiveness and 7-2 with one abstention that benefits outweigh risks.
The Boston Globe reports the system will cut its Home Hospital program to no more than 30 patients, down from about 70 in 2024, while losing about $30 million a year.
The union will vote on a final contract offer, while MGB also manages an insurance network change and a network outage.
The 42-year-old woman travelled from Uganda to Abuja and tested positive on October 20. Forty-four contacts have been identified, mostly health workers.
The health ministry says nine cases are confirmed, all within one cluster linked to the index patient, as the outbreak has now reached four African countries.
The patient had travelled through Uganda, but exposure remains unclear as the rare Bundibugyo strain reaches four countries.
